Trials / Completed
CompletedNCT00671502
A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back
Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 840 (actual)
- Sponsor
- Meda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.
Detailed description
Methodology: This was a randomized, double-blind, double-dummy, placebo-controlled, parallel-group study in subjects 18-70 years of age with acute, painful, muscle spasm of the lower back. The study consisted of a baseline screening (Study Day 1), during which subjects were evaluated for inclusion/exclusion criteria, and a 7-day double-blind treatment period (Study Day 1 through Study Day 7). Subjects were randomly assigned to be dosed twice daily with one of the following double-blind treatments: sustained release(SR) carisoprodol 500-mg tablets,sustained release (SR) carisoprodol 700-mg tablets, or placebo. Subjects were evaluated in the clinic on Study Days 1, 3 and 7. Subjects who remained symptomatic on Study Day 7 were allowed to continue in the study for a 7-day, double-blind extension period at the discretion of the Investigator. Subjects were contacted by telephone for a safety follow-up 7 days after the last dose of study medication. A pharmacokinetic (PK) substudy was conducted at selected sites. These sites obtained blood samples for PK analysis at the end of the 7-day treatment period and the 14-day treatment period, if applicable.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carisoprodol SR | 700 mg twice daily |
| DRUG | Carisoprodol SR | 500 mg twice daily |
| DRUG | Placebo | Placebo tablet |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-05-05
- Last updated
- 2011-11-09
- Results posted
- 2011-11-09
Locations
68 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00671502. Inclusion in this directory is not an endorsement.